Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (81-90 of 401) with videos related to

Pageof 41
Sort By:
Clinical Cardiology|April 16, 2010
Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrelSteen Husted, Robert F Storey, Robert A Harrington, et al.
European Heart Journal|December 25, 2019
Intolerance to aspirin in patients undergoing percutaneous coronary intervention in the setting of chronic coronary syndromes: perspectives from the ESC 2019 Chronic Coronary Syndromes guidelinesRobert F Storey, Marco Valgimigli, Thomas Cuisset, et al.
Journal of Clinical Pharmacology|November 19, 2016
Exposure-Response Analyses Supporting Ticagrelor Dosing Recommendation in Patients With Prior Myocardial InfarctionDaniel Röshammar, Joakim Nyberg, Tomas Andersson, et al.
Hospital Practice (1995)|March 13, 2012
Contemporary management of ST-segment elevation myocardial infarctionArun Karunakaran, Wael Sumaya, Julian P Gunn, et al.
Thrombosis and Haemostasis|May 1, 2010
Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet functionHeather M Judge, Robert J Buckland, Atsuhiro Sugidachi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 27, 2004
Clopidogrel resistanceStan Heptinstall, Jackie R Glenn, Jane A May, et al.
Cardiovascular Research|February 11, 2014
Vessel wall, not platelet, P2Y12 potentiates early atherogenesisLaura E West, Tanja Steiner, Heather M Judge, et al.
Platelets|February 26, 2008
The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responsesHeather M Judge, Robert J Buckland, Atsuhiro Sugidachi, et al.
European Heart Journal. Case Reports|May 25, 2026
Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinibOmar Dirir, William A E Parker, Hazel A Haley, et al.
Pharmacology & Therapeutics|June 24, 2010
Current strategies in antiplatelet therapy--does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?Tobias Geisler, Meinrad Gawaz, Steven R Steinhubl, et al.
Pageof 41

Showing results (81-90 of 401) with videos related to

Sort By:
Pageof 41
Clinical Cardiology|April 16, 2010
Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrelSteen Husted, Robert F Storey, Robert A Harrington, et al.
European Heart Journal|December 25, 2019
Intolerance to aspirin in patients undergoing percutaneous coronary intervention in the setting of chronic coronary syndromes: perspectives from the ESC 2019 Chronic Coronary Syndromes guidelinesRobert F Storey, Marco Valgimigli, Thomas Cuisset, et al.
Journal of Clinical Pharmacology|November 19, 2016
Exposure-Response Analyses Supporting Ticagrelor Dosing Recommendation in Patients With Prior Myocardial InfarctionDaniel Röshammar, Joakim Nyberg, Tomas Andersson, et al.
Hospital Practice (1995)|March 13, 2012
Contemporary management of ST-segment elevation myocardial infarctionArun Karunakaran, Wael Sumaya, Julian P Gunn, et al.
Thrombosis and Haemostasis|May 1, 2010
Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet functionHeather M Judge, Robert J Buckland, Atsuhiro Sugidachi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 27, 2004
Clopidogrel resistanceStan Heptinstall, Jackie R Glenn, Jane A May, et al.
Cardiovascular Research|February 11, 2014
Vessel wall, not platelet, P2Y12 potentiates early atherogenesisLaura E West, Tanja Steiner, Heather M Judge, et al.
Platelets|February 26, 2008
The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responsesHeather M Judge, Robert J Buckland, Atsuhiro Sugidachi, et al.
European Heart Journal. Case Reports|May 25, 2026
Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinibOmar Dirir, William A E Parker, Hazel A Haley, et al.
Pharmacology & Therapeutics|June 24, 2010
Current strategies in antiplatelet therapy--does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?Tobias Geisler, Meinrad Gawaz, Steven R Steinhubl, et al.
Pageof 41